Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
ALK translocation
i
Other names:
NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Associations
(9)
News
Trials
A2 | Sensitive
B | Sensitive
C2 | Sensitive
C4 | Sensitive
A2 | Resistant
B | Resistant
C2 | Resistant
C4 | Resistant
Show legend
Drug categories
Tyrosine Kinase Inhibitors
EGFR
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cancel
Soft Tissue Sarcoma
Non Small Cell Lung Cancer
crizotinib
A2
ALK translocation
|
Soft Tissue Sarcoma
|
crizotinib
C2
ALK translocation
|
Non Small Cell Lung Cancer
|
crizotinib
ceritinib
A2
ALK translocation
|
Soft Tissue Sarcoma
|
ceritinib
lorlatinib
A2
ALK translocation
|
Soft Tissue Sarcoma
|
lorlatinib
brigatinib
A2
ALK translocation
|
Soft Tissue Sarcoma
|
brigatinib
ALK inhibitor
C4
ALK translocation
|
Non Small Cell Lung Cancer
|
ALK inhibitor
ABCP
B
ALK translocation
|
Non Small Cell Lung Cancer
|
ABCP
durvalumab
C2
ALK translocation
|
Non Small Cell Lung Cancer
|
durvalumab
tislelizumab
C2
ALK translocation
|
Non Small Cell Lung Cancer
|
tislelizumab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login